Steven Pieper
Chief Financial Officer · Xeris Biopharma Holdings, Inc.
- 2024
- Oct 2, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Steven Pieper files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kevin McCulloch - $1.36M in XERS purchases and sales in the last 12 months
- Beth Hecht - $1.34M in XERS purchases and sales in the last 12 months
- John Patrick Shannon Jr. - $173K in XERS purchases and sales in the last 12 months
- Dawn Halkuff - $122K in XERS purchases and sales in the last 12 months
- Barbara-Jean Anne Bormann-Kennedy - $98K in XERS purchases and sales in the last 12 months
- Marla Persky - $91K in XERS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Steven Pieper?
Steven Pieper is a corporate insider, tracked as Chief Financial Officer of Xeris Biopharma Holdings, Inc. (XERS). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Steven Pieper submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Steven Pieper been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($515K) across all tracked filings.
